World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

Press releases published on May 30, 2026

May 30, 2026

Author Ani Retak Unveils 'Breathe Wisely': A Self-Help Guide on Breath and Nervous System Awareness

Indeterminate EIN Presswire

May 30, 2026

Synergy Rehab Continues Expanding Multidisciplinary Rehabilitation Across British Columbia With Patient-First Care

Indeterminate EIN Presswire

May 30, 2026

Julianna Carella to Appear on Kingdom Creators TV

Indeterminate EIN Presswire

May 30, 2026

Jordan Czerner Garcia to Appear on Love Experts TV

Indeterminate EIN Presswire

May 30, 2026

Jason and Silvana Busch to Appear on America’s Top Trainers TV

Indeterminate EIN Presswire

May 30, 2026

More Families Are Choosing Outdoor-Focused Road Trip Vacations in Utah

Indeterminate EIN Presswire

May 30, 2026

The Growing Conversation Around Oxygen Therapy and Cellular Recovery

Indeterminate EIN Presswire

May 30, 2026

Erica Rojas to Appear on Mompreneurs TV

Indeterminate EIN Presswire

May 30, 2026

Dr. Cintia Ciriaco to Appear on America’s Best Doctors TV

Indeterminate EIN Presswire

May 30, 2026

Carlos A. Reyes to Appear on Legacy Makers TV

Indeterminate EIN Presswire

May 30, 2026

Pompa Program Surpasses 1,300 Trustpilot Ratings with 4.7/5 Star Average

Indeterminate GlobeNewswire

May 30, 2026

Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours

Indeterminate GlobeNewswire

May 30, 2026

Orion Pharma julkisti ensimmäiset tulokset Faasi 1/2 TEADES-tutkimuksesta ODM-212-molekyylillä (TEAD-estäjä) potilailla, joilla on kiinteitä kasvaimia ja edennyt syöpä

Indeterminate GlobeNewswire

May 30, 2026

Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology

Indeterminate GlobeNewswire

May 30, 2026

Globale Daten der ROSETTA Lung-02-Studie: Ermutigende Wirksamkeit für BioNTechs und Bristol Myers Squibbs bispezifischen PD-L1xVEGF-A-Immunmodulator-Kandidat Pumitamig bei nicht-kleinzelligem Lungenkrebs

Indeterminate GlobeNewswire

May 30, 2026

Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial

Indeterminate GlobeNewswire

May 30, 2026

ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026

Indeterminate GlobeNewswire

May 30, 2026

Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)

Indeterminate GlobeNewswire

May 30, 2026

Vapofil Reviews [URGENT REPORT 2026] The Shocking VapoFil Male Enhancement Supplement Trend Everyone Is Talking About

Indeterminate GlobeNewswire

May 30, 2026

ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026

Indeterminate GlobeNewswire